Biotech's Take on the 2016 Election
By A.J. Fezza
The 2016 presidential primary race is heating up, with vicious exchanges between candidates in televised debates and violent disputes between people for and against Trump in places like Chicago.
On the Republican side, Donald Trump originally held a comfortable lead over the other candidates. Trump’s lead began to minimize when other candidates such as Ted Cruz and John Kasich won considerably major states such as Iowa and Ohio. However, Trump still holds a fairly comfortable lead over his competitors. As of March 20, 2016, Trump has 678 delegates, Cruz has 423 delegates, and Kasich has 143 delegates of the needed 1237 to win the Republican nomination. Marco Rubio, who just dropped out of the race on March 15, 2016, had 172 delegates.
Meanwhile, on the Democratic side, Hillary Clinton is holding a fairly comfortable lead over Bernie Sanders, yet the race is still heated and contentious. Clinton has 1132 delegates, while Sanders has 818 delegates of the needed 2,383 delegates needed to win the Democratic nomination. Sanders has a major lead over Clinton among voters in the New England region, and voters under the age of 24, while Clinton leads Sanders among African-Americans, Hispanics, and older voters.
The trend of social liberalism and support for Sanders among younger voters applies to Biotech as well, according to a school-wide poll in the first week of February. This poll also stated that Biotech students tend to be fiscally moderate, socially liberal, and care most about issues regarding education and the economy. Here is a more in-depth look at the results below: